Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03783442
Brief Title: A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma

First Submitted : December 18, 2018
First Submitted that Met QC Criteria : December 19, 2018
First Posted : December 21, 2018

Last Update Submitted that Met QC Criteria : November 1, 2019
Last Update Posted : November 4, 2019